Point-of-care testing for viral-associated pulmonary aspergillosis

References

• Bongomin F, Gago S, Oladele RO, et al. Global and multi-National prevalence of fungal Diseases-estimate precision. J Fungi (Basel). 2017;3(4). doi: 10.3390/jof3040057
   Google Scholar
• Hoenigl M, Seidel D, Sprute R, et al. COVID-19-associated fungal infections. Nat Microbiol. 2022 Aug 2;7(8):1127–1140. doi: 10.1038/s41564-022-01172-2
   PubMed Web of Science ®Google Scholar
• Fisher MC, Denning DW. The WHO fungal priority pathogens list as a game-changer. Nat Rev Microbiol. 2023 Apr;21(4):211–212. doi: 10.1038/s41579-023-00861-x
   PubMed Web of Science ®Google Scholar
• Latgé JP, Chamilos G. Aspergillus fumigatus and aspergillosis in 2019. Clin Microbiol Rev. 2019 Dec 18;33(1). doi: 10.1128/CMR.00140-18
   PubMed Web of Science ®Google Scholar
• Jenks JD, Nam HH, Hoenigl M. Invasive aspergillosis in critically ill patients: review of definitions and diagnostic approaches. Mycoses. 2021 Mar 24;64(9):1002–1014.
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Seidel D, Carvalho A, et al. The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet Microbe. 2022 Jan 25;3(7):e543–e552. doi: 10.1016/S2666-5247(21)00237-8
   PubMedGoogle Scholar
• Özbek L, Topçu U, Manay M, et al. COVID-19–associated mucormycosis: a systematic review and meta-analysis of 958 cases. Clin Microbiol Infect. 2023 Mar 13;29(6):722–731. doi: 10.1016/j.cmi.2023.03.008
   PubMed Web of Science ®Google Scholar
• Schauwvlieghe AFAD, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018;6(10): 782–792.
   PubMed Web of Science ®Google Scholar
• Salazar F, Bignell E, Brown GD, et al. Pathogenesis of respiratory viral and fungal coinfections. Clin Microbiol Rev. 2022 Jan 19;35(1):e0009421. doi: 10.1128/CMR.00094-21
   PubMed Web of Science ®Google Scholar
• Feys SG, Khan SM, CHoi M, et al. An observational study of lung epithelial and myeloid immunity in influenza- and COVID-19-associated pulmonary aspergillosis. Lancet Respir Med. 2022;10(12):1147–1159. doi: 10.1016/S2213-2600(22)00259-4
   PubMed Web of Science ®Google Scholar
• Reizine F, Pinceaux K, Lederlin M, et al. Influenza- and COVID-19-Associated pulmonary aspergillosis: are the pictures different? J Fungi (Basel). 2021 May 15;7(5):388. doi: 10.3390/jof7050388
   PubMedGoogle Scholar
• Gangneux JP, Hoenigl M, Papon N. How to lose resistance to Aspergillus infections. Trends Microbiol. 2023 Mar;31(3):222–224. doi: 10.1016/j.tim.2023.01.008
   PubMed Web of Science ®Google Scholar
• Arastehfar A, Carvalho A, van de Veerdonk FL, et al. COVID-19 associated pulmonary aspergillosis (CAPA)—from immunology to treatment. JoF. 2020 Jun 24;6(2):91. doi: 10.3390/jof6020091
   Google Scholar
• Arastehfar A, Carvalho A, Houbraken J, et al. Aspergillus fumigatus and aspergillosis: from basics to clinics. Stud Mycol. 2021 Sep;100(1):100115. doi: 10.1016/j.simyco.2021.100115
   PubMedGoogle Scholar
• Cricca M, Pascale R, Bartoletti M, et al. Clinical impact of Renin-angiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for coronavirus disease 2019. Clin Infect Dis. 2020 Jul 28;71(15):899–901. doi: 10.1093/cid/ciaa492
   PubMed Web of Science ®Google Scholar
• Janssen NAF, Nyga R, Vanderbeke L, et al. Multinational observational cohort study of COVID-19-Associated pulmonary Aspergillosis(1). Emerg Infect Dis. 2021 Nov;27(11):2892–2898. doi: 10.3201/eid2711.211174
   PubMed Web of Science ®Google Scholar
• Gangneux JD, Fekkar E, Luyt A, et al. Fungal infections in mechanically ventilated COVID-19 patients in the ICU during the 1 first wave: the French multicenter MYCOVID study. Lancet Resp Med. 2022;10(2): 180–190.
   PubMed Web of Science ®Google Scholar
• Koehler P, Denis B, Denning DW, et al. European confederation of medical mycology expert consult—an ECMM excellence center initiative. Mycoses. 2020 Mar 17;63(6):566–572. doi: 10.1111/myc.13076
   PubMed Web of Science ®Google Scholar
• Verweij PE, Rijnders BJA, Brüggemann RJM, et al. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive care Med. 2020;46(8):1524–1535. doi: 10.1007/s00134-020-06091-6
   PubMed Web of Science ®Google Scholar
• Hong W, White PL, Backx M, et al. CT findings of COVID-19-associated pulmonary aspergillosis: a systematic review and individual patient data analysis. Clin Imaging. 2022 Oct;90:11–18.
   PubMed Web of Science ®Google Scholar
• Vanderbeke L, Spriet I, Breynaert C, et al. Invasive pulmonary aspergillosis complicating severe influenza: epidemiology, diagnosis and treatment. Curr Opin Infect Dis. 2018 Dec;31(6):471–480. doi: 10.1097/QCO.0000000000000504
   PubMed Web of Science ®Google Scholar
• Giacobbe DR, Prattes J, Wauters J, et al. Prognostic impact of bronchoalveolar lavage fluid galactomannan and Aspergillus culture results on survival in COVID-19 intensive care unit patients: a Post Hoc analysis from the European confederation of Medical mycology (ECMM) COVID-19-Associated pulmonary aspergillosis study. J Clin Microbiol. 2022 Mar 24;60(4):e0229821. doi: 10.1128/jcm.02298-21
   PubMed Web of Science ®Google Scholar
• Koehler P, Cornely OA, Böttiger BW, et al. COVID-19 associated pulmonary aspergillosis. Mycoses. 2020 Apr 27;63(6):528–534. doi: 10.1111/myc.13096
   PubMed Web of Science ®Google Scholar
• Prattes J, Wauters J, Giacobbe DR, et al. Diagnosis and treatment of COVID-19 associated pulmonary aspergillosis in critically ill patients: results from a European confederation of medical mycology registry. Intensive care Med. 2021 Jul 16;47(10):1158–1160. doi: 10.1007/s00134-021-06471-6
   PubMed Web of Science ®Google Scholar
• Salmanton-García J, Hoenigl M, Gangneux JP, et al. The current state of laboratory mycology and access to antifungal treatment in Europe: a European confederation of Medical mycology survey. Lancet Microbe. 2023 Jan;4(1):e47–e56. doi: 10.1016/S2666-5247(22)00261-0
   PubMedGoogle Scholar
• Chindamporn A, Chakrabarti A, Li R, et al. Survey of laboratory practices for diagnosis of fungal infection in seven Asian countries: an Asia fungal working group (AFWG) initiative. Med Mycol. 2018;56(4):416–425. doi: 10.1093/mmy/myx066
   PubMed Web of Science ®Google Scholar
• Salmanton-García J, Au WY, Hoenigl M, et al. The current state of laboratory mycology in Asia/Pacific: a survey from the European confederation of Medical mycology (ECMM) and international society for human and animal mycology (ISHAM). Int J Antimicrob Agents. 2023 Jan;11(3):106718. doi: 10.1016/j.ijantimicag.2023.106718
   Google Scholar
• Mikulska M, Furfaro E, Dettori S, et al. Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients. Mycoses. 2022 Apr;65(4):411–418. doi: 10.1111/myc.13428
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Egger M, Price J, et al. Metagenomic next-generation sequencing of plasma for diagnosis of COVID-19-Associated pulmonary aspergillosis. J Clin Microbiol. 2023;61(3):e01859–22. doi: 10.1128/jcm.01859-22
   PubMed Web of Science ®Google Scholar
• Gangneux JP, Reizine F, Guegan H, et al. Is the COVID-19 pandemic a good time to include Aspergillus molecular detection to categorize aspergillosis in ICU patients? A monocentric experience. J Fungi (Basel). 2020 Jul 10;6(3):105. doi: 10.3390/jof6030105
   PubMedGoogle Scholar
• Heldt S, Prattes J, Eigl S, et al. Diagnosis of invasive aspergillosis in hematological malignancy patients: performance of cytokines, asp LFD, and Aspergillus PCR in Same day blood and bronchoalveolar lavage samples. J Infect. 2018;77(3):235–241. doi: 10.1016/j.jinf.2018.05.001
   PubMed Web of Science ®Google Scholar
• Jenks JD, Mehta SR, Taplitz R, et al. Point-of-care diagnosis of invasive aspergillosis in non-neutropenic patients: aspergillus galactomannan lateral flow assay versus Aspergillus-specific lateral flow device test in bronchoalveolar lavage. Mycoses. 2019 Mar;62(3):230–236. doi: 10.1111/myc.12881
   PubMed Web of Science ®Google Scholar
• Lass-Flörl C, Samardzic E, Knoll M. Serology anno 2021—fungal infections: from invasive to chronic. Clin Microbiol Infect. 2021;27(9):1230–1241. doi: 10.1016/j.cmi.2021.02.005
   PubMed Web of Science ®Google Scholar
• Autier B, Prattes J, White PL, et al. Aspergillus lateral flow assay with digital reader for the diagnosis of COVID-19-Associated pulmonary aspergillosis (CAPA): a multicenter study. J Clin Microbiol. 2022 Jan 19;60(1):e0168921. doi: 10.1128/JCM.01689-21
   PubMed Web of Science ®Google Scholar
• Egger M, Prüller F, Krause R, et al. Utility of serum 1,3-β-d-glucan testing for diagnosis and prognostication in COVID-19-Associated pulmonary aspergillosis. Microbiol Spectr. 2022 May 31;10(3):e0137322. doi: 10.1128/spectrum.01373-22
   PubMed Web of Science ®Google Scholar
• Jenks JD, Prattes J, Frank J, et al. Performance of the bronchoalveolar lavage fluid Aspergillus galactomannan lateral flow assay with Cube reader for diagnosis of invasive pulmonary aspergillosis: a multicenter cohort study. Clinl Infect Dis. 2021;73(7):e1737–e1744. doi: 10.1093/cid/ciaa1281
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Egger M, Boyer J, et al. Serum lateral flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: a two Center mixed cohort study. Mycoses. 2021 Jul 12;64(10):1197–1202. doi: 10.1111/myc.13352
   PubMed Web of Science ®Google Scholar
• Mercier T, Dunbar A, de Kort E, et al. Lateral flow assays for diagnosing invasive pulmonary aspergillosis in adult hematology patients: a comparative multicenter study. Med Mycol. 2019;58(4):444–452. doi: 10.1093/mmy/myz079
   Web of Science ®Google Scholar
• Swanink CM, Meis JF, Rijs AJ, et al. Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol. 1997;35(1):257–260. doi: 10.1128/jcm.35.1.257-260.1997
   PubMed Web of Science ®Google Scholar
• Verweij PE, Dompeling EC, Donnelly JP, et al. Serial monitoring of Aspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples. Infection. 1997;25(2):86–89. doi: 10.1007/BF02113581
   PubMed Web of Science ®Google Scholar
• Thornton CR. Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis. Clin Vaccine Immunol. 2008;15(7):1095–1105. doi: 10.1128/CVI.00068-08
   PubMed Web of Science ®Google Scholar
• Wiederhold NP, Thornton CR, Najvar LK, et al. Comparison of lateral flow Technology and galactomannan and (1→3)-β- d -glucan assays for detection of invasive pulmonary aspergillosis. Clin Vaccine Immunol. 2009;16(12):1844–1846. doi: 10.1128/CVI.00268-09
   PubMedGoogle Scholar
• Castillo CG, Kauffman CA, Zhai J, et al. Testing the performance of a prototype lateral flow device using bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in high-risk patients. Mycoses. 2018;61(1):4–10. doi: 10.1111/myc.12694
   PubMed Web of Science ®Google Scholar
• Delama I, Legarraga P, González T, et al. Evaluación del Aspergillus lateral flow device para el diagnóstico de aspergilosis invasora, experiencia en un hospital universitario. Rev Chil Infectol. 2018;35(5):574–579. doi: 10.4067/s0716-10182018000500574
   PubMedGoogle Scholar
• Eigl S, Prattes J, Lackner M, et al. Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients. Crit Care. 2015;19:178-015-0905–x. doi: 10.1186/s13054-015-0905-x
   Web of Science ®Google Scholar
• Eigl S, Prattes J, Reinwald M, et al. Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test. Int J Antimicrob Agents. 2015;46(4):401–405. doi: 10.1016/j.ijantimicag.2015.05.017
   PubMed Web of Science ®Google Scholar
• Willinger B, Lackner M, Lass-Flörl C, et al. Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis in solid organ transplant patients: a semi-Prospective multicenter study. Transplantation. 2014; accepted manuscript.
   Google Scholar
• Prattes J, Lackner M, Eigl S, et al. Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients. Mycoses. 2015;58(8):461–469. doi: 10.1111/myc.12343
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Prattes J, Spiess B, et al. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol. 2014;52(6):2039–2045. doi: 10.1128/JCM.00467-14
   PubMed Web of Science ®Google Scholar
• Prattes J, Flick H, Prüller F, et al. Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases. Am J Respir Crit Care Med. 2014 [2014 Oct 15];190(8):922–929. doi: 10.1164/rccm.201407-1275OC
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Koidl C, Duettmann W, et al. Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients. J Infect. 2012 [2012 Dec];65(6):588–591. doi: 10.1016/j.jinf.2012.10.003
   PubMed Web of Science ®Google Scholar
• Johnson GL, Sarker SJ, Nannini F, et al. Aspergillus-specific lateral-flow device and real-time PCR testing of bronchoalveolar lavage fluid: a Combination biomarker approach for clinical diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol. 2015;53(7):2103–2108. doi: 10.1128/JCM.00110-15
   PubMed Web of Science ®Google Scholar
• Miceli MH, Goggins MI, Chander P, et al. Performance of lateral flow device and galactomannan for the detection of Aspergillus species in bronchoalveolar fluid of patients at risk for invasive pulmonary aspergillosis. Mycoses. 2015;58(6):368–374. doi: 10.1111/myc.12327
   PubMed Web of Science ®Google Scholar
• White PL, Parr C, Thornton C, et al. Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis. J Clin Microbiol. 2013;51(5):1510–1516. doi: 10.1128/JCM.03189-12
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Eigl S, Heldt S, et al. Clinical evaluation of the newly formatted lateral-flow device for invasive pulmonary aspergillosis. Mycoses. 2018;61(1):40–43. doi: 10.1111/myc.12704
   PubMed Web of Science ®Google Scholar
• Jenks JD, Mehta SR, Taplitz R, et al. Bronchoalveolar lavage Aspergillus galactomannan lateral flow assay versus Aspergillus-specific lateral flow device test for diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies. J Infect. 2019 [2019 Mar 1];78(3):249–259. doi: 10.1016/j.jinf.2018.10.014
   PubMed Web of Science ®Google Scholar
• Mercier T, Guldentops E, Lagrou K, et al. Prospective evaluation of the turbidimetric beta-D-Glucan assay and 2 lateral flow assays on serum in invasive aspergillosis. Clin Infect Dis. 2021 May 4;72(9):1577–1584. doi: 10.1093/cid/ciaa295
   PubMed Web of Science ®Google Scholar
• Mercier T, Dunbar A, de Kort E, et al. Lateral flow assays for diagnosing invasive pulmonary aspergillosis in adult hematology patients: a comparative multicenter study. Med Mycol. 2020 [2020 Jun 1];58(4):444–452. doi: 10.1093/mmy/myz079
   PubMed Web of Science ®Google Scholar
• Scharmann U, Verhasselt HL, Kirchhoff L, et al. Evaluation of two lateral flow assays in BAL fluids for the detection of invasive pulmonary aspergillosis: a retrospective two-centre study. Mycoses. 2020 [2020 Dec];63(12):1362–1367. doi: 10.1111/myc.13176
   PubMed Web of Science ®Google Scholar
• White PL, Price JS, Posso R, et al. Evaluation of the performance of the IMMY sona Aspergillus galactomannan lateral flow assay when testing serum to aid in diagnosis of invasive aspergillosis. J Clin Microbiol. 2020 May 26;58(6): doi: 10.1128/JCM.00053-20
   Web of Science ®Google Scholar
• Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clinl Infect Dis. 2020 [2020 Sep 15];71(6):1367–1376. doi: 10.1093/cid/ciz1008
   PubMed Web of Science ®Google Scholar
• Koehler P, Bassetti M, Chakrabarti A, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021 [2021 Jun];21(6):e149–e162. doi: 10.1016/S1473-3099(20)30847-1
   PubMed Web of Science ®Google Scholar
• Linder KA, Kauffman CA, Miceli MH. Performance of Aspergillus galactomannan lateral flow assay on bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis.J Fungi (Basel). 2020 [2020 Nov 18];6(4):E297. doi: 10.3390/jof6040297
   PubMedGoogle Scholar
• Mercier T, Dunbar A, Veldhuizen V, et al. Point of care aspergillus testing in intensive care patients. Crit Care. 2020 [2020 Nov 10];24(1):642. doi: 10.1186/s13054-020-03367-7
   PubMed Web of Science ®Google Scholar
• Roman-Montes CM, Martinez-Gamboa A, Diaz-Lomelí P, et al. Accuracy of galactomannan testing on tracheal aspirates in COVID-19-associated pulmonary aspergillosis. Mycoses. 2021 [2021 Apr];64(4):364–371. doi: 10.1111/myc.13216
   PubMed Web of Science ®Google Scholar
• Ghazanfari M, Yazdani Charati J, Davoodi L, et al. Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis. Mycoses. 2022 Oct;65(10):960–968. doi: 10.1111/myc.13518
   PubMed Web of Science ®Google Scholar
• Marta G-C, Lorena F-E, Laura M-V, et al. COVID-19-Associated pulmonary aspergillosis in a tertiary hospital. Journal Of Fungi. 2022 [2022 Feb];8(2):97. doi: 10.3390/jof8020097
   Web of Science ®Google Scholar
• Egger M, Penziner S, Dichtl K, et al. Performance of the Euroimmun Aspergillus antigen ELISA for the diagnosis of invasive pulmonary aspergillosis in bronchoalveolar lavage fluid. J Clin Microbiol. 2022 Apr 20;60(4):e0021522. doi: 10.1128/jcm.00215-22
   PubMed Web of Science ®Google Scholar
• Almeida-Paes R, Almeida MA, de Macedo PM, et al. Performance of two commercial assays for the detection of serum Aspergillus galactomannan in non-neutropenic patients. JoF. 2022 Jul 18;8(7):741. doi: 10.3390/jof8070741
   Google Scholar
• Hsiao HH, Liu YC, Wang HC, et al. Comparison of a novel lateral-flow device to galactomannan assay at different time periods for detections of invasive aspergillosis. J Formos Med Assoc. 2022 Oct;121(10):2123–2129. doi: 10.1016/j.jfma.2022.04.011
   PubMed Web of Science ®Google Scholar
• Serin I, Baltali S, Cinli TA, et al. Lateral flow assay (LFA) in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a single-center experience. BMC Infect Dis. 2022 Nov 8;22(1):822. doi: 10.1186/s12879-022-07828-y
   PubMed Web of Science ®Google Scholar
• Giusiano G, Fernández NB, Vitale RG, et al. Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina. Med Mycol. 2022 May 18;60(5): doi: 10.1093/mmy/myac026
   Web of Science ®Google Scholar
• Wiederhold NP, Najvar LK, Bocanegra R, et al. Interlaboratory and interstudy reproducibility of a novel lateral-flow device and influence of antifungal therapy on detection of invasive pulmonary aspergillosis. J Clin Microbiol. 2013;51(2):459–465. doi: 10.1128/JCM.02142-12
   PubMed Web of Science ®Google Scholar
• Dufresne SF, Datta K, Li X, et al. Detection of urinary excreted fungal galactomannan-like antigens for diagnosis of invasive aspergillosis. PLoS One. 2012;7(8):e42736. doi: 10.1371/journal.pone.0042736
   PubMed Web of Science ®Google Scholar
• Marr KA, Datta K, Mehta S, et al. Urine antigen detection as an aid to diagnose invasive aspergillosis. Clin Infect Dis. 2018; doi: 10.1093/cid/ciy326
   PubMed Web of Science ®Google Scholar
• Kriegl L, Havlicek V, Dichtl K, et al. Siderophores: a potential role as a diagnostic for invasive fungal disease. Curr Opin Infect Dis. 2022 Aug 4;35(6):485–492. doi: 10.1097/QCO.0000000000000862
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Orasch T, Faserl K, et al. Triacetylfusarinine C: a urine biomarker for diagnosis of invasive aspergillosis. J Infect. 2019 Feb;78(2):150–157. doi: 10.1016/j.jinf.2018.09.006
   PubMed Web of Science ®Google Scholar
• Reischies FM, Raggam RB, Prattes J, et al. Urine galactomannan-to-creatinine ratio for detection of invasive aspergillosis in patients with hematological malignancies. J Clin Microbiol. 2016;54(3):771–774. doi: 10.1128/JCM.02969-15
   PubMed Web of Science ®Google Scholar
• Salonen J, Lehtonen OP, Terasjarvi MR, et al. Aspergillus antigen in serum, urine and bronchoalveolar lavage specimens of neutropenic patients in relation to clinical outcome. Scand J Infect Dis. 2000;32(5):485–490. doi: 10.1080/003655400458749
   PubMedGoogle Scholar
• Duettmann W, Koidl C, Troppan K, et al. Serum and urine galactomannan testing for screening in patients with hematological malignancies. Med Mycol. 2014;52(6):647–652. doi: 10.1093/mmy/myu019
   PubMed Web of Science ®Google Scholar
• Buil JB, Huygens S, Dunbar A, et al. Retrospective multicenter evaluation of the VirClia galactomannan antigen assay for the diagnosis of pulmonary aspergillosis with bronchoalveolar lavage fluid samples from patients with hematological disease. J Clin Microbiol. 2023 [2023 Apr 25];61(5):e0004423. doi: 10.1128/jcm.00044-23
   PubMed Web of Science ®Google Scholar
• Singh S, Kanaujia R, Agnihotri S, et al. The comparative evaluation of the Fujifilm Wako β-glucan assay and Fungitell assay for diagnosing invasive fungal disease. J Fungi (Basel). 2022 [2022 Dec 20];9(1):6. doi: 10.3390/jof9010006
   PubMedGoogle Scholar
• Mercier T, Guldentops E, Patteet S, et al. Beta-d-glucan for diagnosing pneumocystis pneumonia: a direct comparison between the Wako β-glucan assay and the fungitell assay. J Clin Microbiol. 2019 [2019 May 24];57(6). doi: 10.1128/JCM.00322-19
   Web of Science ®Google Scholar
• Bergeron A, Porcher R, Sulahian A, et al. The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies. Blood. 2012;119(8):1831–1837. quiz 1956. doi: 10.1182/blood-2011-04-351601
   PubMed Web of Science ®Google Scholar
• Mercier T, Castagnola E, Marr KA, et al. Defining galactomannan positivity in the Updated EORTC/MSGERC consensus definitions of invasive fungal Diseases. Clinl Infect Dis. 2021 [2021 Mar 15];72(Supplement_2):S89–S94. doi: 10.1093/cid/ciaa1786
   PubMedGoogle Scholar
• Bassetti M, Giacobbe DR, Grecchi C, et al. Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: a systematic review with qualitative evidence synthesis. J Infect. 2020 Apr 21;81(1):131–146. doi: 10.1016/j.jinf.2020.03.065
   PubMed Web of Science ®Google Scholar
• Bassetti M, Scudeller L, Giacobbe DR, et al. Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections definitions in ICU patients (FUNDICU) project. Mycoses. 2019 Apr;62(4):310–319. doi: 10.1111/myc.12869
   PubMed Web of Science ®Google Scholar
• Blot SI, Taccone FS, Van den Abeele A-M, et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2012 [2012 Jul 1];186(1):56–64. doi: 10.1164/rccm.201111-1978OC
   PubMed Web of Science ®Google Scholar
• Bassetti M, Azoulay E, Kullberg BJ, et al. EORTC/MSGERC definitions of invasive fungal Diseases: summary of activities of the Intensive care unit Working group. Clin Infect Dis. 2021 Mar 12;72(Supplement_2):S121–s127. doi: 10.1093/cid/ciaa1751
   PubMedGoogle Scholar
• Jenks JD, Hoenigl M. Point-of-care diagnostics for invasive aspergillosis: nearing the finish line. Expert Rev Mol Diagn. 2020 Sep;14:1–9.
   Google Scholar
• Kimura S-I, Odawara J, Aoki T, et al. Detection of sputum Aspergillus galactomannan for diagnosis of invasive pulmonary aspergillosis in haematological patients. Int J Hematol. 2009 [2009 Nov];90(4):463–470. doi: 10.1007/s12185-009-0429-8
   PubMed Web of Science ®Google Scholar
• Nyga R, Maizel J, Nseir S, et al. Invasive tracheobronchial aspergillosis in critically ill patients with severe influenza. A clinical trial. Am J Respir Crit Care Med. 2020 Sep 1;202(5):708–716. doi: 10.1164/rccm.201910-1931OC
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Egger M, Boyer J, et al. Serum lateral flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: a two-centre mixed cohort study. Mycoses. 2021 Oct;64(10):1197–1202. doi: 10.1111/myc.13352
   PubMed Web of Science ®Google Scholar
• Prattes J, Wauters J, Giacobbe DR, et al. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients- a multinational observational study by the European confederation of Medical mycology. Clin Microbiol Infect. 2021 Aug 25; doi: 10.2139/ssrn.3868099
   Web of Science ®Google Scholar
• Cordonnier C, Botterel F, Ben Amor R, et al. Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis. Clin Microbiol Infect. 2009 Jan;15(1):81–86. doi: 10.1111/j.1469-0691.2008.02122.x
   PubMed Web of Science ®Google Scholar
• Dagenais TR, Keller NP. Pathogenesis of Aspergillus fumigatus in invasive aspergillosis. Clin Microbiol Rev. 2009 Jul;22(3):447–465. doi: 10.1128/CMR.00055-08
   PubMed Web of Science ®Google Scholar
• Ergun M, Bruggemann RJM, Alanio A, et al. Aspergillus test profiles and mortality in critically ill COVID-19 patients. J Clin Microbiol. 2021 Nov 18;59(12):e0122921. doi: 10.1128/JCM.01229-21
   PubMed Web of Science ®Google Scholar
• Ergün M, Brüggemann RJM, Alanio A, et al. Aspergillus test profiles and mortality in critically-ill COVID-19 patients. J Clin Microbiol. 2021 Sep 8;59(12): Jcm0122921. doi: 10.1128/JCM.01229-21
   PubMed Web of Science ®Google Scholar
• Dellière S, Dudoignon E, Voicu S, et al. Combination of mycological criteria: a better surrogate to identify COVID-19 associated pulmonary aspergillosis patients and evaluate prognosis? J Clin Microbiol. 2022 Jan 5;60(3): Jcm0216921. doi: 10.1128/jcm.02169-21
   PubMed Web of Science ®Google Scholar
• Bartoletti M, Pascale R, Cricca M, et al. Epidemiology of invasive pulmonary aspergillosis among intubated patients with COVID-19: a Prospective study. Clin Infect Dis. 2021 Dec 6;73(11):e3606–e3614. doi: 10.1093/cid/ciaa1065
   PubMed Web of Science ®Google Scholar
• Koehler P, Bassetti M, Chakrabarti A, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. The Lancet Infectious Diseases. 2020 2020 Dec 14.
   PubMed Web of Science ®Google Scholar
• Verweij PE, Brüggemann RJM, Azoulay E, et al. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis. Intensive care Med. 2021 Aug;47(8):819–834. doi: 10.1007/s00134-021-06449-4
   PubMed Web of Science ®Google Scholar
• De Pascale G, Martin-Loeches I, Nseir S. Antifungal stewardship in critically ill patients.Intensive care Med. 2023 [2023 Mar 24];49(6):681–684. doi: 10.1007/s00134-023-07034-7
   PubMed Web of Science ®Google Scholar
• Aerts R, Cuypers L, Mercier T, et al. Implementation of lateral flow assays for the diagnosis of invasive aspergillosis in European Hospitals: a survey from Belgium and a literature review of test performances in different patient populations. Mycopathologia. 2023, [2023 May 20]; doi: 10.1007/s11046-023-00739-9
   PubMed Web of Science ®Google Scholar
• Mercier T, Guldentops E, Lagrou K, et al. Prospective evaluation of the turbidimetric β-D-Glucan assay and 2 lateral flow assays on serum in invasive aspergillosis. Clinical Infectious Diseases. 2020 Mar 19;72(9):1577–1584. doi: 10.1093/cid/ciaa295
   Web of Science ®Google Scholar
• Forster J, Hoenigl M, Suerbaum S, et al. Serologic biomarkers in Candida and Aspergillus infections of the central nervous system: a comparison of galactomannan, mannan and β-1, 3-D -gucan testing from serum and cerebrospinal fluid. Mycoses. 2022;65(7):709–714. doi: 10.1111/myc.13451
   PubMed Web of Science ®Google Scholar
• White PL, Jones T, Whittle K, et al. Comparison of galactomannan enzyme immunoassay performance levels when testing serum and plasma samples. Clin Vaccine Immunol. 2013;20(4):636–638. doi: 10.1128/CVI.00730-12
   PubMedGoogle Scholar